New evidence is suggesting that the risk of pancreatitis and other problems may be increased by a group of recently approved diabetes drugs. The Food and Drug Administration is looking into the discovery that samples of pancreas tissue taken from a small number of patients showed inflammation and cellular changes that often precede cancer. Researchers obtained the samples from patients with diabetes that were taking the new medications, after they died from various causes. Details of the research... 

In his lectures, Dr. Robert Lustig of the University of California, San Francisco, explains in depth how the sweeteners that have been added to our food contributes to obesity and other metabolic disorders. Dr. Lustig has written a best-selling book, Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity and Disease. He has also released a popular YouTube lecture, “Sugar: The Bitter Truth,”, and had a subsequent profile in the New York Times Magazine. In a new study, Dr. Lustig and... 

Consuming only one can per day of sugar-laced drinks increases a person’s risk by more than 20% of developing diabetes, according to a European large-scale study published this week. Data was used from more than 350,000 people living in eight countries in Europe. Researchers found that for every additional 12 fluid oz, serving of drinks sweetened with sugar increased the risk of developing diabetes by 22% compared with only drinking one can per month or less. Doctors said that because of the increase... 

The U.S. Food and Drug Administration has approved the Johnson & Johnson drug Invokana, following data that showed it had been effective in reducing the blood sugar in patients who have Type 2 diabetes, which is the most common type of the disease. Five postmarketing studies have been asked for by the FDA for the newly approved drug, including a trial for cardiovascular outcomes, a program for enhanced pharmacovigilance, a study for bone safety and two studies for pediatrics. Invokana is estimated... 

Binge drinking can have scary health consequences. Researchers from the Mount Sinai School of Medicine report that binge drinking may increase a person’s risk of developing type 2 diabetes. Frequent binge drinking has also been linked to risky sexual behavior, an increased risk for alcohol addiction, and chronic conditions such as heart disease and hypertension. The results of the study were published in the journal Science Translational Medicine. The study reviewed the results in rats that were... 

The U.S. Food and Drug Administration has started to examine drugs that treat Type 2 Diabetes because of the possibility they aid in the development of pancreatic cancer. Two drugs are currently being examined – Byetta developed by Bristol-Myers Squibb and Merck’s Januvia. Statistics suggest in the U.S. that nearly 25 million people suffer from one of the types of diabetes. The cost of treating diabetes in the U.S. is over $245 billion annually. Medical experts also said that options in forms... 

Over the past five years, the cost of fighting diabetes in the U.S. has increased by 41%, according to a new study. Diabetes cost is growing in the U.S. and reached a new high of more than $245 billion during 2012, which was 41% higher than the $174 billion spent in 2007. The new study, which the American Diabetes Association commissioned, estimated the work-related and healthcare costs of diabetes diagnosed in the U.S. The primary cause why the cost of diabetes has increased, according to the study,... 

By drinking only one 12 ounce can of a fizzy drink  each day the risk of Type 2 diabetes developing is increased, according to a new study recently completed by researchers from the University of California at Berkley, the University of California at San Francisco and Palo Alto, California’s Stanford University. Type 2 diabetes can be life threatening and scientists found that calorie, which are sugar based, like the ones in carbonated or fizzy drinks more likely cause that type of diabetes, than... 

On Thursday, a new drug being developed by Johnson & Johnson was given backing by an advisory panel that voted 10 to 5 in favor of recommending the drug to the U.S. Food and Drug Administration. If approved, the drug would be the first of a new type of medication in the United States that treats diabetes. Nevertheless, a number of the panel members raised concerns over the drug’s potential risks when used in patients suffering from impaired kidneys. They also were concerned with the cardiovascular... 

Eli Lilly said on Monday a diabetes treatment it is testing with Boehringer a German drug maker proved to be more effective than just a placebo in the preliminary results from four late-stage trials. The drug developer based in Indianapolis said the new treatment, a tablet taken once per day, known as empagliflozin is designed to reduce the levels of blood sugar in patients that have type 2 diabetes. The results showed that the new treatment fared better when it was used alone. The two pharmaceutical...